Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. - Saltz,L.B.; Clarke,S.; Díaz-Rubio,E. (J Clin Oncol, 2008)